Related Articles
Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathway
Müllerian inhibiting substance/anti‑Müllerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria
Vascular endothelial growth factor induces anti‑Müllerian hormone receptor 2 overexpression in ovarian granulosa cells of in vitro fertilization/intracytoplasmic sperm injection patients
Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival
A heterozygous missense SCN5A mutation associated with early repolarization syndrome